BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 6874333)

  • 21. [Primary cutaneous lymphoma--mycosis fungoides].
    Nagatani T; Okazawa H; Mizuno H; Yanagi N; Miyazawa M; Baba N
    Gan To Kagaku Ryoho; 1997 Jan; 24(1):23-9. PubMed ID: 9020941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of radiation therapy in mycosis fungoides refractory to systemic therapy.
    de Sanctis V; Persechino S; Fanelli A; Valeriani M; Bracci S; D'Arienzo M; Monarca B; Caperchi C; Raffa S; Enrici RM
    Eur J Dermatol; 2011; 21(2):213-7. PubMed ID: 21489904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Report of the Committee on Therapy for Mycosis Fungoides and Sézary Syndrome.
    Minna JD; Roenigk HH; Glatstein E
    Cancer Treat Rep; 1979 Apr; 63(4):729-36. PubMed ID: 109209
    [No Abstract]   [Full Text] [Related]  

  • 24. Electron-beam therapy for mycosis fungoides: the Stanford University experience.
    Hoppe RT; Cox RS; Fuks Z; Price NM; Bagshaw MA; Farber EM
    Cancer Treat Rep; 1979 Apr; 63(4):691-700. PubMed ID: 109207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plaque stage mycosis fungoides treated with bexarotene at low dosage and UVB-NB.
    D'Acunto C; Gurioli C; Neri I
    J Dermatolog Treat; 2010 Jan; 21(1):45-8. PubMed ID: 19603308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response of mycosis fungoides to topical chemotherapy with mechlorethamine.
    Ramsay DL; Parnes RE; Dubin N
    Arch Dermatol; 1984 Dec; 120(12):1585-90. PubMed ID: 6508330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical chemotherapy and immunotherapy of mycosis fungoides: intermediate-term results.
    Vonderheid EC; Van Scott EJ; Johnson WC; Grekin DA; Asbell SO
    Arch Dermatol; 1977 Apr; 113(4):454-62. PubMed ID: 848974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local radiation and phototherapy are the most cost-effective treatments for stage IA mycosis fungoides: A comparative decision analysis model in the United States.
    Xia FD; Ferket BS; Huang V; Stern RS; Wu PA
    J Am Acad Dermatol; 2019 Feb; 80(2):485-492.e4. PubMed ID: 30081119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical nitrogen mustard in early mycosis fungoides. A 12-year experience.
    Zachariae H; Thestrup-Pedersen K; Søgaard H
    Acta Derm Venereol; 1985; 65(1):53-8. PubMed ID: 2578706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic approaches in cutaneous lymphoma.
    Jörg B; Kerl H; Thiers BH; Bröcker EB; Burg G
    Dermatol Clin; 1994 Apr; 12(2):433-41. PubMed ID: 8045054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycosis fungoides palmaris et plantaris--an unusual variant of cutaneous T-cell lymphoma.
    Topf S; Lüftl M; Neisius U; Brabletz T; Simon M; Schuler G; Schultz ES
    Eur J Dermatol; 2006; 16(1):84-6. PubMed ID: 16436350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skin directed therapy for mycosis fungoides: a review.
    Berthelot C; Rivera A; Duvic M
    J Drugs Dermatol; 2008 Jul; 7(7):655-66. PubMed ID: 18664158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Milia in regressing plaques of mycosis fungoides: provoked by topical nitrogen mustard or not?
    Kalayciyan A; Oguz O; Demirkesen C; Serdaroglu S; Kotogyan A
    Int J Dermatol; 2004 Dec; 43(12):953-6. PubMed ID: 15569030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome.
    Trautinger F; Knobler R; Willemze R; Peris K; Stadler R; Laroche L; D'Incan M; Ranki A; Pimpinelli N; Ortiz-Romero P; Dummer R; Estrach T; Whittaker S
    Eur J Cancer; 2006 May; 42(8):1014-30. PubMed ID: 16574401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultimate results of radiation therapy for T1-T2 mycosis fungoides (including reirradiation).
    Ysebaert L; Truc G; Dalac S; Lambert D; Petrella T; Barillot I; Naudy S; Horiot JC; Maingon P
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1128-34. PubMed ID: 15001254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma.
    Talpur R; Venkatarajan S; Duvic M
    Expert Rev Clin Pharmacol; 2014 Sep; 7(5):591-7. PubMed ID: 25068889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Change of level of mycosis fungoides under systemic PUVA-therapy (author's transl)].
    Tourbier H; Schultz-Ehrenburg U
    Z Hautkr; 1981 Jul; 56(14):923-9. PubMed ID: 7269717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides.
    Chinn DM; Chow S; Kim YH; Hoppe RT
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):951-8. PubMed ID: 10192339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined modality therapy for cutaneous T-cell lymphoma.
    Duvic M; Lemak NA; Redman JR; Eifel PJ; Tucker SL; Cabanillas FF; Kurzrock R
    J Am Acad Dermatol; 1996 Jun; 34(6):1022-9. PubMed ID: 8647968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mycosis fungoides. Clinical characteristics and treatment of 6 patients].
    Dotterud LK; Aarstein K; Falk ES
    Tidsskr Nor Laegeforen; 1991 Jun; 111(15):1850-2. PubMed ID: 1853318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.